Zoetis Inc. Shares Drop After Lowering Full-Year Guidance

Zoetis Inc. saw its shares underperform during the second quarter of 2026 after the animal health company reported flat organic revenue growth and reduced its full-year guidance. The company attributed the decline to a drop in veterinary visits and softening demand for companion-animal products within the United States, alongside increased market competition.

These financial results sparked investor concerns regarding a potential near-term earnings gap. Specifically, there are worries that slowing growth in the company's legacy portfolio may outpace the contributions of new pipeline products.

As of July 31, 2026, Zoetis Inc. shares closed at $77.29, representing a 47.91% loss over the preceding 52 weeks.